Literature DB >> 6396769

Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.

C Tormey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6396769     DOI： 10.1007/978-3-642-82357-2_19

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  2 in total

1.  Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centre.

Authors:  L Mauriac; M Durand; J Chauvergne; F Bonichon; A Avril; P Mage; M H Dilhuydy; A Le Treut; J Wafflart; D Marée
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

2.  West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes.

Authors:  J M Morrison; A Howell; K A Kelly; R J Grieve; I J Monypenny; R A Walker; J A Waterhouse
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.